Development and evaluation of carvedilol transdermal patches

Acta Pharmaceutica

Volumn 57, Issue 2, 2007, Pages 151-159

  Tanwar, Yuveraj Singh ^a   Chauhan, Chetan Singh ^a   Sharma, Anshu ^a  

^a Bhupal Noble's College of Pharmacy   (India)

Author keywords

Carvedilol; In vitro permeation; Permeation rate; Transdermal patches

Indexed keywords

CARVEDILOL; EUDRAGIT; EUDRAGIT RS; HYDROXYPROPYLMETHYLCELLULOSE; POLYSORBATE 80; PROPYLENE GLYCOL; SORBITAN OLEATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG PENETRATION; EVAPORATION; FEMALE; GUINEA PIG; IN VITRO STUDY; MALE; MOISTURE; NONHUMAN; PHYSICAL CHEMISTRY; SKIN IRRITATION; TRANSDERMAL PATCH; VAPOR;

EID: 34248586701     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0012-x     Document Type: Article

References (17)

1. R. R. Ruffolo, Jr. and G. Z. Feuerstein, Pharmacology of carvedilol: rational for use in hypertension, coronary artery disease, and congestive heart failure, Cardiovasc. Drugs Ther. 11 (1997) 247-256.
2. th ed., Mc Graw Hill, New York 2001, p. 1936.
3. th ed., Mc. Graw Hill, New York 2001, p. 447.
4. U. V. Singh, S. Pandey and N. Udupa, Preparation and evaluation of flurbiprofen and diclofenac sodium transdermal films, Indian J. Pharm. Sci. 54 (1993) 145-147.
5. P. Arora and B. Mukherjee, Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt, J. Pharm. Sci. 91 (2002) 2076-2089.
6. C. Amnuaikit, I. Ikeuchi, K. Ogawara, K. Higaki and T. Kimura, Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use, Int. J. Pharm. 289 (2005) 167-178.
7. P. R. P. Verma and S. S. Iyer, Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 26 (2000) 471-476.
8. V. K. Devi, S. Saisivam, G. R. Maria and P. U. Deepti, Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride, Drug Dev. Ind. Pharm. 29 (2003) 495-503.
9. R. Krishna and J. K. Pandit, Transdermal delivery of propranolol, Drug Dev. Ind. Pharm. 20 (1994) 2459-2465.
10. P. R. Keshary and Y. W. Chien, Mechanisms of transdermal nitroglycerin administration (I): development of finite-dosing skin permeation system, Drug Dev. Ind. Pharm. 10 (1984) 883-913.
11. G. K. Jain, A. K. Sharma and S. S. Agarwal, Transdermal controlled administration of verapamil-enhancement of skin permeability, Int. J. Pharm. 130 (1996) 169-177.
12. J. H. Draize, G. Woodard and H. O. Calvery, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, J. Pharmacol. Exp. Ther. 82 (1944) 377-390.
13. C.-W. Cho and S.-C. Shin, Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix, Inf. J. Pharm. 287 (2004) 67-71.
14. R. W. Korsmeyer, R. Gurny, E. M. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35.
15. P. L. Ritger and N. A. Peppas, Simple equation for solute release. Part 1. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks, J. Control. Rel. 5 (1987) 37-42.
16. V. Rao and S. Shyale, Preparation and evaluation of ocular inserts containing norfloxacin, Turk J. Med. Sci. 34 (2004) 239-246.
17. S. K. Sahoo, A. A. Mallick, B. B. Barik and P. Ch. Senapati, Formulation and in vitro evaluation of eudragit microspheres of stavudine, Trop. J. Pharm. Res. 4 (2005) 369-375.